GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Value Added Technology Co 043150.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

16,720

+0.48%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩426.42bn

FY2016FY2025

Net income

₩40.13bn

FY2016FY2025

Free cash flow

₩49.02bn

FY2016FY2025

Shareholders' equity

₩495.70bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩426.42bn₩385.19bn₩384.95bn₩395.06bn₩338.98bn₩244.31bn₩271.70bn₩234.39bn₩218.81bn₩178.56bn
Gross profit₩221.23bn₩204.18bn₩205.18bn₩205.15bn₩165.60bn₩113.43bn₩127.69bn₩111.75bn₩104.95bn₩75.80bn
Research and development₩13.67bn₩14.25bn₩14.29bn₩11.20bn₩11.35bn₩7.97bn₩6.52bn₩4.46bn₩4.37bn₩3.29bn
Operating income₩54.78bn₩53.79bn₩57.33bn₩79.45bn₩62.48bn−₩23.03bn₩42.01bn₩39.35bn₩39.07bn₩29.85bn
Net income₩40.13bn₩55.13bn₩51.73bn₩76.89bn₩51.24bn−₩24.22bn₩33.88bn₩27.26bn₩79.09bn₩24.77bn
Diluted earnings per share2,701.403,711.623,482.805,176.323,449.20-1,630.472,280.951,835.075,324.281,667.27

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩689.27bn₩650.29bn₩586.90bn₩511.11bn₩419.98bn₩353.87bn₩386.99bn₩349.62bn₩321.48bn₩390.17bn
Cash and short-term investments—₩109.89bn₩95.67bn₩89.52bn₩105.13bn₩90.96bn₩52.70bn₩48.50bn₩31.46bn₩112.70bn
Total liabilities₩191.75bn₩179.80bn₩172.71bn₩161.83bn₩146.75bn₩131.36bn₩138.48bn₩130.49bn₩125.46bn₩243.35bn
Debt₩98.8m₩43.59bn₩36.16bn₩26.57bn₩21.52bn₩32.22bn₩35.61bn₩47.45bn₩54.03bn₩71.60bn
Shareholders' equity₩495.70bn₩453.42bn₩398.65bn₩349.29bn₩273.22bn₩222.51bn₩248.51bn₩219.12bn₩196.02bn₩146.82bn
Shares outstanding15m15m15m15m15m15m15m15m15m15m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩60.32bn₩39.35bn₩49.31bn₩33.34bn₩44.13bn₩51.14bn₩40.67bn₩33.24bn₩51.00bn₩32.24bn
Capital spending−₩11.30bn−₩24.45bn−₩45.45bn−₩14.37bn−₩12.14bn−₩5.04bn−₩5.00bn−₩4.82bn−₩16.35bn−₩33.42bn
Free cash flow₩49.02bn₩14.90bn₩3.86bn₩18.98bn₩31.99bn₩46.10bn₩35.68bn₩28.42bn₩34.65bn−₩1.18bn
Dividends paid−₩1.49bn−₩2.13bn−₩1.49bn−₩1.49bn−₩1.49bn−₩2.88bn−₩2.72bn−₩1.49bn−₩1.49bn−₩1.49bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩121.36bn₩105.20bn₩114.37bn₩100.11bn₩110.62bn₩101.32bn₩101.71bn₩87.28bn
Gross profit₩69.71bn₩53.62bn₩60.17bn₩51.66bn₩55.77bn₩53.64bn₩52.58bn₩47.31bn
Operating income₩24.47bn₩10.99bn₩12.29bn₩12.40bn₩16.88bn₩13.20bn₩10.20bn₩12.41bn
Net income₩22.41bn₩14.45bn₩6.64bn₩13.89bn₩7.30bn₩12.31bn₩15.90bn₩7.11bn
Diluted earnings per share1,508.58972.93446.73934.83491.27828.571,070.24478.98
Cash from operations₩13.58bn₩962.0m₩25.32bn₩10.70bn₩14.55bn₩9.76bn₩20.14bn₩10.38bn
Capital spending−₩959.0m−₩920.0m−₩4.08bn−₩1.71bn−₩3.47bn−₩2.03bn−₩2.31bn−₩9.00bn
Free cash flow₩12.62bn₩42.0m₩21.24bn₩8.98bn₩11.07bn₩7.73bn₩17.83bn₩1.38bn
Total assets₩742.76bn₩715.45bn₩689.27bn₩658.61bn₩646.95bn₩666.63bn₩650.29bn₩619.89bn
Cash and short-term investments—————₩122.54bn₩109.89bn₩87.95bn
Debt₩40.9m₩68.2m₩98.8m₩127.0m₩153.6m₩25.12bn₩22.93bn₩37.71bn
Shareholders' equity₩535.73bn₩510.50bn₩495.70bn₩486.17bn₩470.75bn₩469.54bn₩453.42bn₩436.42bn

Financial ratios

Data as of 3 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin51.9%53.0%53.3%51.9%48.9%46.4%——
Operating margin12.8%14.0%14.9%20.1%18.4%-9.4%——
Net margin9.4%14.3%13.4%19.5%15.1%-9.9%——
Return on equity8.1%12.2%13.0%22.0%18.8%-10.9%——
Return on assets5.8%8.5%8.8%15.0%12.2%-6.8%——
Free cash flow yield——————16.4%13.7%
Revenue growth10.7%0.1%-2.6%16.5%38.7%-10.1%——
Earnings growth-27.2%6.6%-32.7%50.1%-311.5%-171.5%——
Current ratio3.10x2.85x2.79x2.68x2.53x2.36x——
Debt to equity0.00x0.02x0.06x0.03x0.06x0.12x——
Equity ratio71.9%69.7%67.9%68.3%65.1%62.9%——
Interest coverage21.20x24.14x22.76x50.36x69.97x-18.14x——
R&D as a share of sales3.2%3.7%3.7%2.8%3.3%3.3%——
Buybacks as a share of market value——————0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.6%11.8%7.0%
Operating income-11.7%—2.9%
Net income-19.5%—6.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin52.4%52.5%51.3%49.6%
Operating margin13.4%15.4%13.1%14.4%
Net margin11.7%14.1%11.5%13.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings7.25.19.66.310.3-13.812.811.86.421.7
Price to sales0.70.71.31.21.61.41.61.42.33.0

Dividends and splits

Per share, in the currency the company pays

Paid for 17 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year400.00100.00100.00100.00100.00100.00100.00100.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.